SLI
2.022,65
PKT
+7,85
PKT
+0,39
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.06.14 | Novartis buy | UBS AG | |
| 18.06.14 | Novartis Outperform | Bernstein Research | |
| 18.06.14 | UBS buy | Citigroup Corp. | |
| 18.06.14 | UBS buy | Citigroup Corp. | |
| 17.06.14 | UBS neutral | Macquarie Research | |
| 17.06.14 | UBS Outperform | Macquarie Research | |
| 16.06.14 | ABB (Asea Brown Boveri) Outperform | Credit Suisse Group | |
| 16.06.14 | Givaudan buy | Nomura | |
| 16.06.14 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 13.06.14 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 13.06.14 | UBS Hold | Société Générale Group S.A. (SG) | |
| 13.06.14 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
| 12.06.14 | UBS buy | Citigroup Corp. | |
| 11.06.14 | UBS buy | Citigroup Corp. | |
| 10.06.14 | Nestlé Halten | Independent Research GmbH | |
| 09.06.14 | UBS overweight | JP Morgan Chase & Co. | |
| 09.06.14 | Novartis Equal weight | Barclays Capital | |
| 06.06.14 | Nestlé overweight | Morgan Stanley | |
| 06.06.14 | Nestlé overweight | JP Morgan Chase & Co. | |
| 04.06.14 | UBS buy | Goldman Sachs Group Inc. | |
| 04.06.14 | UBS Conviction Buy | Goldman Sachs Group Inc. | |
| 04.06.14 | Novartis Hold | Deutsche Bank AG | |
| 04.06.14 | Roche buy | Deutsche Bank AG | |
| 03.06.14 | Novartis buy | Société Générale Group S.A. (SG) | |
| 03.06.14 | Roche overweight | JP Morgan Chase & Co. | |
| 03.06.14 | Novartis Halten | Independent Research GmbH | |
| 03.06.14 | UBS buy | Deutsche Bank AG | |
| 03.06.14 | UBS buy | Deutsche Bank AG | |
| 03.06.14 | UBS buy | UBS AG | |
| 03.06.14 | Nestlé Neutral | Goldman Sachs Group Inc. | |
| 02.06.14 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 02.06.14 | Roche buy | Société Générale Group S.A. (SG) | |
| 02.06.14 | Novartis Underweight | Morgan Stanley | |
| 02.06.14 | Roche overweight | Morgan Stanley | |
| 02.06.14 | Nestlé Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.05.14 | Holcim overweight | JP Morgan Chase & Co. | |
| 30.05.14 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 30.05.14 | UBS buy | Deutsche Bank AG | |
| 30.05.14 | UBS buy | Deutsche Bank AG | |
| 29.05.14 | Zurich Insurance Neutral | Citigroup Corp. |